Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Editorial Board

    Editorial Board

    Editor-in-Chief

     

    Associate Editors

    • Sinisa Radulovic, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, 11000
    • Lei Yang, Nanjing Medical University, China
    • Strashimir Karanov, National Cancer Center hospital, Sofia, 1756 Bulgaria
    • Munir Kinay, Chairman of Dokuz Eylul University Oncology Institute at Dokuz Eylul University, Izmir, Turkey
    • Dimitrios Trafalis, Medical Oncologist at University of Athens, School of Medicine, Athens, Greece
    • Dimitrios Moris, Department of Surgery, Duke University Medical Center, Durham, NC, USA

     

    Editorial Office: editorial_office@jbuon.com

    Editorial Board

    • Vasile Musteata, State University of Medicine and Pharmacy, ‘N Testemitanu’, Institute of Oncology, Chisinau, Republic of Moldova.
    • P. Achimas-Cadariu, Faculty of Medicine, “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
    • M. Alakavuklar, Department of Medical Oncology, Kent Hospital, Izmir, Turkey
    • I. Alexandru, Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania
    • K. Altundag, MKA Breast Cancer Clinic, Ankara, Turkey
    • G. Androutsos, Biomedical Research Foundation, Academy of Athens, Athens, Greece
    • R. Anghel, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
    • J.P. Armand, Medical Oncology, Institute Gustave Roussy and Institute Curie, Toulouse, France
    • J.O. Armitage, University of Nebraska Medical Center, Omaha, USA
    • N. Arsenijević, Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
    • R.C. Bast Jr, Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, USA
    • A. Bikfalvi, University of Bordeaux, Pessac, France
    • G. Bogdanović, Department of Experimental Oncology, Institute of Oncology Sremska Kamenica, Serbia
    • N. Bountouroglou, Department of Radiation Oncology-A, Metaxa Cancer Hospital, Piraeus, Greece
    • M. Branković-Magić, Institute for Oncology and Radiology of Serbia, Beograd, Yugoslavia
    • S. Brkić, University of Novi Sad, Faculty of Medicine, Serbia
    • P.A. Bunn Jr, Division of Medical Oncology, University of Colorado, Denver, USA
    • K. Christov, Department of Surgical Oncology and Cancer Center, University of Illinois at Chicago, Chicago, USA
    • T. Ciuleanu, Oncology Institute Ion Chiricuta, Cluj-Napoca, Romania
    • D. Delgado, Health & Territory Research of the Universidad de Sevilla, Seville, Spain
    • H.-J. Li, Affiliated 5 to Nantong University, Taizhou, China
    • V. Diehl, University Clinics Cologne, Koln, Germany
    • C. Dittrich, Kaiser Franz Josef-Spital, Vienna, Austria
    • T. Dragovich, University of Arizona Cancer Center, Tucson, USA
    • I. Duran, Hospital Universitario Virgen del Rocio, Seville, Spain
    • A. Eniu, Department of Breast Tumours, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania
    • S. Filipović, University of Nis, Faculty of Medicine, Clinic of Oncology, Nis, Serbia
    • E.J. Freirech, The University of Texas, MD Anderson Cancer Center, Houston, USA
    • X.-J. Cao, Jiangsu Province Hospital, Nanjing, China
    • C. Gavrilovic, Institute for Oncology and Radiology of Serbia, Beograd, Serbia
    • G. Geromichalos, Laboratory of Inorganic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece
    • L. Gocheva, University Hospital “Queen Giovanna-ISUL” Department of Radiotherapy, Sofia, Bulgaria
    • A. Perin, Institute for Pulmonary Diseases of Vojvodina, University of Novi Sad, Topolsica, Slovenia
    • A. Grivas, Department of Medical Oncology, Metaxa Cancer Hospital, Piraeus, Greece
    • S. Guadagni, Department of Applied Clinical Sciences and Biotechnology, University of L’Aquila, L’Aquila, Italy
    • S.Guler, Kocaeli University Medical Faculty, Dept.of General Surgery, Izmir, Turkey
    • H. Hansen, Department of Oncology, Finsen Centre, Copenhagen, Denmark
    • A. Haydaroglu, Department of Radiation Oncology, Ege University Faculty of Medicine, Izmir, Turkey
    • J.C. Holland, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, USA
    • J.C. Horiot, Centre Georges-François Leclerc, Dijon, France
    • R. Igić, Department of Anesthesiology and Pain Management, Stroger Hospital of Cook County, Chicago, USA
    • A. Irimie, Department of Surgery, The Oncology Institute “Prof. Dr. Ion Chiricuta”, Cluj-Napoca, Romania
    • L. Wan, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, China
    • G. Karikas, Department of Medical Laboratories, Faculty of Health and Caring Professions, Technological Educational Institute of Athens, Athens, Greece
    • S.B. Kaye, Department of Medical Oncology, University of Glasgow, Garcube Estate, Glasgow, UK
    • A. Klein, Institute of Oncology, Meir Medical Center, Kfar Saba, Israel
    • M. Kontos, First Department of Surgery, ‘Laikon’ General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
    • E. Lianos, Department of Medical Oncology A’, “Metaxa” Cancer Hospital, Piraeus, Greece
    • S. Linardopoulos, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK
    • I. Lubinski, Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Center, Szczecin, Poland
    • V. Malamou-Mitsi, Department of Pathology, University of Ioannina School of Medicine, Ioannina, Greece
    • M. Malumbres, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
    • L. Yang, Nanjing Medical University, Nanjing, China
    • A. Mandić, University of Novi Sad, School of Medicine, Novi Sad, Serbia
    • G. Marjanović, Department of Haematology and Clinical Immunology, Clinical Center Nis and Medical Faculty, University of Nis, Nis, Serbia
    • J. Meletis, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece
    • L. Miron, Department of Clinics, Faculty of Veterinary Medicine, Iasi, Romania
    • A. Molassiotis, School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK
    • A. Nersesyan, Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
    • L. Ozguroglu, Istanbul University, Cerrahpasa Medical Faculty, Division of Medical Oncology, Istanbul, Turkey
    • A.D. Purushotham, Cambridge Breast Unit, Addenbrookes Hospital, Cambridge, UK
    • D. Radosavljević, Department of Medical Oncology, University of Belgrade, Belgrade, Serbia
    • D. Raghavan, Cleveland Clinic Taussig Cancer Center, 9500 Euclid Avenue Cleveland, Ohio, USA
    • G. Rigatos, St. Savas Anticancer Hospital, Athens, Greece
    • S. Ruacan, Department of Pathology, Medical Faculty of Hacettepe University, Ankara, Turkey
    • P. Rusu, Department of Radiotherapy, Institute of Oncology Prof. Ion Chiricuta, Cluj-Napoca, Romania
    • S. Sahin, Diskapi Yildirim Beyazit Training and Research hosp., Dept of Medical Oncology, Ankara, Turkey
    • M. Sakizli, Medical Biology and Genetics Department, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey
    • M.A.N Sendur, Faculty of Medicine, Department of Medical Oncology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey
    • J.F. Smyth, Cancer Research Centre Western General Hospital, University of Edinburgh, Edinburgh, UK
    • D. Spandidos, Medical School, University of Crete, Heraklion, Crete, Greece
    • J. Syrios, Department of Medical Oncology A’, “Metaxa” Cancer Hospital, Athens, Greece
    • I. Tannock, Division of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada
    • L. Teppo, Finnish Cancer Registry, Helsinki, Finland
    • A. Thanos, Department of Urology, General Hospital of Athens, Athens, Greece
    • E. Tsiambas, Department of Cytology, 417 Veterans Army Hospital (NIMTS), Athens, Greece
    • D. Tural, Department of Internal Medicine, Division of Medical Oncology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
    • A.T. Van Oosterom, Department of Oncology, University Hospitals Leuven, Leuven, Belgium
    • J.B. Vermorken, Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium
    • S.G. Vitale, University of Messina, Catania, Italy
    • C. Vlad, Department of Oncology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
    • P.A. Voûte, Emma Kinderziekenhuis, Academic Medical Center, Amsterdam, The Netherlands
    • E. Wagner, Nanosystems Initiative Munich (NIM), Munich, Germany
    • J. Tang, Department of Plastic Surgery, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
    • D. Yannoukakos, Molecular Diagnostics Laboratory, I/RRP, National Centre for Scientific Research Demokritos, Athens, Greece
    • Alparslan Merdin, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey
    • R.F. Ozols, Medical Science Department, Fox Chase Cancer Center, Philadelphia, USA
    • G. Panagos, Department of Medical Oncology, Agii Anargiri Cancer Hospital, Kifisia, Athens, Greece
    • H.M. Pinedo, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    Don't Miss
    Volume 27, 2024

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Dimosthenis Chrysikos1, Spiros Delis2, Charina Triantopoulou2, Evgenia Charitaki2, Nikos Kokoroskos2, Nikolaos Taprantzis1*, Amir Shihada1, Konstantinos…

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025

    Abdominal Aortic Aneurysm and Radiation Therapy

    October 28, 2024
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.